APUS Hisse Senedi Fiyat Grafiği
APUS Finansal
Apimeds Pharmaceuticals US Inc
$1.88
0%
$0
Kapanışta: Apr 16, 16:00:00 GMT-4
$1.88
0%
$0
Sonrası Piyasa: Apr 16, 18:08:29 GMT-4
Geri
Apimeds Pharmaceuticals US Inc (APUS) Finansal
Önemli İstatistikler
Önceki Kapanış
$1.88
Açılış fiyatı
$1.69
Günün Aralığı
$1.69 - $1.88
52 haftalık aralık
$1.6 - $40.31
İşlem hacmi
31.5K
Ort.Hacim
17.9K
Dividend yield
--
EPS (TTM)
--
Piyasa Değeri
$23.6M
APUS nedir?
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
Özellikler
Kaynaklar
© 2026 Finture Development Limited. Tüm hakları saklıdır.